Results 121 to 130 of about 74,841 (314)
Neurologic uses of botulinum neurotoxin type A
, 2007 John P Ney, Kevin R JosephMadigan Army Medical Center, Neurology Service, Tacoma, WA, USAAbstract: This article reviews the current and most neurologic uses of botulinum neurotoxin type A (BoNT-A), beginning with relevant historical data, neurochemical ...
Kevin R Joseph, John P Ney
core
Advancing Personalized Care for Neurogenic Bladder: The Case for Continent Urinary Diversion
Neurourology and Urodynamics, EarlyView.ABSTRACT Introduction Neurogenic lower urinary tract dysfunction (NLUTD) with a poorly compliant bladder that is refractory to minimally invasive therapies (MIT) represents an “end‐stage” phenotype in which the principal objectives are durable upper urinary tract protection and restoration of continence with acceptable long‐term morbidity.
Francis A. Jefferson, Maude E. Carmel
wiley +1 more source
Use of Botulinum Neurotoxin in Ophthalmology
, 2016 Botulinum neurotoxin (BoNT) is the first biological toxin used in the treatment of ophthalmic diseases and to decrease skin wrinkles as an aesthetic agent.
Basar, Emel +3 more
core +1 more source
Urodynamic Voiding Patterns in Multiple Sclerosis
Neurourology and Urodynamics, EarlyView.ABSTRACT Aims This study aimed to describe urodynamic voiding patterns in patients with MS (PwMS) using standardized assessments, and to compare the performance of the available nomograms and indices for obstruction and bladder contractility. Methods PwMS and lower urinary tract symptoms underwent cystometry and pressure flow studies.
Camille Chesnel +5 more
wiley +1 more source
A botulinum toxin farmakológiai felhasználásának lehetőségei
, 2017 A botulinum toxin egy rendkívül erélyes neurotoxin, melyet a Gram-pozítív anaerob spóraképző Clostridium botulinum termel. A toxinnak nyolc szerológiailag eltérő típusát különböztetjük meg az A, B, C (C1, C2), D, E, F, G és H, melyek eltérő antigén ...
Tolnai, Réka
core
Neurourology and Urodynamics, EarlyView.ABSTRACT Introduction Antimuscarinics, as the current first‐line pharmacologic therapies for overactive bladder, exhibit low patient adherence and high rates of reported side effects. As a modern alternative pharmaceutical treatment, beta‐3 agonists, which relax the urinary bladder, may be more tolerable for patients, increasing adherence and ...
Felicity Smith +2 more
wiley +1 more source
Cosmetic use of botulinum toxin type A in the elderly
, 2007 Christine M ChengDepartment of Clinical Pharmacy, University of California, San Francisco, CA, USAAbstract: Botulinum toxin type A injections are one of the most popular cosmetic procedures for diminishing the appearance of facial lines caused by ...
Christine M Cheng
core
Endoscopic small bowel therapies for type 2 diabetes
Nutrition in Clinical Practice, EarlyView.Abstract Type 2 diabetes is a global epidemic despite current medical treatments. Many patients are not responsive to medications, and patients with obesity are hesitant about bariatric surgery. Studies investigating the metabolic effects of Roux‐en‐Y gastric bypass have increasingly demonstrated that the duodenum plays a key role in the ...
Roma Patel +4 more
wiley +1 more source
Neuromodulation: Technology at the Neural Interface, EarlyView., 2021 Abstract Background Refractory chronic migraine (rCM) is a highly disabling condition for which novel safe and effective treatments are needed. Safety and long‐term efficacy of paresthesia‐free high cervical 10 kHz spinal cord stimulation (SCS) were here prospectively evaluated for the treatment of rCM.
Adnan Al‐Kaisy +7 more
wiley +1 more source
Therapeutic Use of Botulinum Toxin in Neurology: a Literature Review
Botulinum toxin (BTX), a neurotoxin produced by Gram-positive Clostridium botulinum, is widely known for its broad application in aesthetic medicine, but it is also playing an increasingly important therapeutic role in neurology.
Natalia Skrzypska +5 more
core +1 more source